Ananda Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is February - January.

Millions GBP. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 5, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	2019 - 2020
Market Capitalization	13	19	9	5	7	1	Upgrade
Market Cap Growth	104.53%	104.53%	73.71%	-24.23%	685.22%	3.09%	Upgrade
Enterprise Value	12	20	9	6	7	1	Upgrade
Last Close Price	0.00	0.00	0.00	0.00	0.01	0.00	Upgrade
PS Ratio	208023.23	308567.77	-	-	-	-	Upgrade
PB Ratio	6.06	8.99	26.62	4.47	24.68	1.09	Upgrade
P/TBV Ratio	18.83	27.93	-	-	24.68	1.09	Upgrade
EV/Sales Ratio	-	318841.81	-	-	-	-	Upgrade
EV/EBITDA Ratio	-	-	20.55	-	-	-	Upgrade
Debt / Equity Ratio	0.57	0.57	6.04	3.06	5.51	0.32	Upgrade
Debt / EBITDA Ratio	-	-	4.67	-	-	-	Upgrade
Quick Ratio	0.72	0.72	0.04	0.04	0.06	0.01	Upgrade
Current Ratio	0.74	0.74	0.05	0.06	0.08	0.03	Upgrade
Return on Equity (ROE)	-304.20%	-304.20%	-790.61%	-174.33%	-173.42%	-48.08%	Upgrade
Return on Assets (ROA)	-54.23%	-54.23%	-36.67%	-14.27%	-33.16%	-22.85%	Upgrade
Return on Capital (ROIC)	-76.78%	-76.78%	-50.37%	-18.73%	-40.79%	-26.65%	Upgrade
Earnings Yield	-29.23%	-19.71%	-65.76%	-24.16%	-13.65%	-54.70%	Upgrade
FCF Yield	-	-4.27%	-7.75%	-8.49%	-	-	Upgrade
Buyback Yield / Dilution	-44.54%	-44.54%	-209.17%	-17.94%	-61.93%	-15.39%	Upgrade

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.